Exelixis (EXEL) Enterprise Value (2010 - 2026)
Exelixis (EXEL) posted quarterly Enterprise Value of -$777.2 million for Q2 2026, up 24.64% year-over-year from -$623.6 million in Q2 2025, and up 26.62% quarter-over-quarter from -$1.1 billion in Q1 2026.
Analysis
Exelixis (EXEL) Enterprise Value (2010 - 2026) Analysis & Trends
Exelixis' Enterprise Value history runs 17 years deep, the most recent figure standing at -$777.2 million for Q2 2026.
- In Q2 2026, Enterprise Value rose 24.64% year-over-year to -$777.2 million; the TTM figure through Apr 2026 stood at -$777.2 million (up 24.64% YoY), while the FY2026 annual figure was -$1.1 billion, up 4.7% from the prior year.
- Enterprise Value for Q2 2026 stood at -$777.2 million, up from -$1.1 billion in the prior quarter.
- The five-year high for Enterprise Value was -$777.2 million in Q2 2026, with the low at -$1.6 billion in Q2 2022.
- The 5-year median for Enterprise Value is -$1.1 billion (2023), against an average of -$1.2 billion.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value plunged 32.46% in 2022, then rose 28.68% in 2023.
- Exelixis' Enterprise Value stood at -$1.3 billion in 2022, then grew by 23.93% to -$995.3 million in 2023, then retreated by 19.48% to -$1.2 billion in 2024, then gained by 16.87% to -$988.5 million in 2025, then advanced by 21.38% to -$777.2 million in 2026.
- Business Quant data shows EXEL's Enterprise Value at -$777.2 million in Q2 2026, -$1.1 billion in Q1 2026, and -$988.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 13.06 Bn |
| Apr 3, 2026 | 10.36 Bn |
| Jan 2, 2026 | 10.38 Bn |
| Oct 3, 2025 | 9.76 Bn |
| Jul 4, 2025 | 11.68 Bn |
| Apr 4, 2025 | 8.48 Bn |
| Jan 3, 2025 | 8.46 Bn |
| Sep 27, 2024 | 6.23 Bn |
| Jun 28, 2024 | 5.41 Bn |
| Mar 29, 2024 | 6.04 Bn |
| Dec 29, 2023 | 6.27 Bn |
| Sep 29, 2023 | 5.69 Bn |
| Jun 30, 2023 | 4.85 Bn |
| Mar 31, 2023 | 4.99 Bn |
| Dec 30, 2022 | 3.89 Bn |
| Sep 30, 2022 | 3.51 Bn |
| Jul 1, 2022 | 5.41 Bn |
| Apr 1, 2022 | 5.76 Bn |
| Dec 31, 2021 | 4.36 Bn |
| Oct 1, 2021 | 5.41 Bn |